Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
Background: The distribution of adverse events (AEs) triggered by immune checkpoint inhibitors (ICIs) across different cancer types has never been demonstrated. Methods: Randomised controlled trials exclusively assessing ICI monotherapy in cohorts of over 100 patients were considered. Our primary ou...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024176281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!